ISSN: 2228-5881 eISSN: 2251-7308

Submit Your Paper Instructions for Authors Aims and Scope Editorial Board Editorial Policies Publication Ethics Indexing Info About APB & Contacts Indexing and Abstracting Articles In Press Archive

Journal Info:

Freq.: Quarterly

eISSN: 2251-7308
pISSN: 2228-5881

Permission: CC By

Platinum Open Access

(no submission or publication fees)

Abstracting and Indexing

PubMed Central, Pubmed,

Emerging Sources Citation Index

Scopus, Google Scholar,

EMBASE/Excerpta Medica

EBSCOhost; CAS: DOAJ

2024, Vol 14, No. 4

Advanced Pharmaceutical Bulletin (APB) is a peer-reviewed multidisciplinary open access journal, covering a wide range of various integrative fields with Pharmaceutical sciences.
APB is the official journal of Drug Applied Research Center and Faculty of Pharmacy, published by TUOMS PRESS, Tabriz University of Medical Sciences.

Publication Advantages in Advanced Pharmaceutical Bulletin are:

Free of charge publication for all types of articles
Fast and constructive peer review
Easy and quick online submission of manuscripts
Author friendly review
Rapid publication by means of running issue concept, which gives authors the benefit of 'No Waiting Time' for the officially accepted manuscripts
Free publication of color images
Worldwide visibility of papers (Open Access Journal)

Short Communication

1. Effects of NDRG2 Overexpression on Metastatic Behaviors of HCT116 Colorectal Cancer Cell Line

Ali Golestan, Abbas Ghaderi, Zahra Mojtahedi*

Adv Pharm Bull. 2017;7(4): 661-664. doi: 10.15171/apb.2017.080

PMCID: PMC5788223 PMID: 29399558 Scopus ID: 85043374839

Article

PDF

XML

Cited By:

Research Article

2. Dihydropyrimidine Dehydrogenase Levels in Colorectal Cancer Cells Treated with a Combination of Heat Shock Protein 90 Inhibitor and Oxaliplatin or Capecitabine

Mahshid Mohammadian, Shima Zeynali-Moghaddam, Mohammad Hassan Khadem Ansari, Yousef Rasmi , Anahita Fathi Azarbayjani , Fatemeh Kheradmand*

Adv Pharm Bull. 2019;9(3): 439-444. doi: 10.15171/apb.2019.052

PMCID: PMC6773945 PMID: 31592113 Scopus ID: 85070448483

Article

PDF

XML

Cited By:

Research Article

3. Restoration of miR-193a-5p and miR-146 a-5p Expression Induces G1 Arrest in Colorectal Cancer through Targeting of MDM2/p53

Saeed Noorolyai , Elham Baghbani , Leili Aghebati Maleki , Amir Baghbanzadeh Kojabad, Dariush Shanehbansdi, Vahid Khaze Shahgoli, Ahad Mokhtarzadeh , Behzad Baradaran*

Adv Pharm Bull. 2020;10(1): 130-134. doi: 10.15171/apb.2020.017

PMCID: PMC6983996 PMID: 32002372 Scopus ID: 85084315763

Article

PDF

Full Text

XML

Cited By:

Research Article

4. Transcriptome Changes in Colorectal Cancer Cells upon Treatment with Avicequinone B

Yanet Ocampo , Daneiva Caro , David Rivera, Jhoan Piermattey, Ricardo Gaitán, Luis A. Franco*

Adv Pharm Bull. 2020;10(4): 638-647. doi: 10.34172/apb.2020.077

PMCID: PMC7539315 PMID: 33062604 Scopus ID: 85090451182

Article

PDF

Suppl 1

Full Text

XML

Cited By:

Review Article

5. Roles of miRNAs in Colorectal Cancer: Therapeutic Implications and Clinical Opportunities

Amir Mehrgou , Shima Ebadollahi, Khaled Seidi, Mohammad Hosein Ayoubi-Joshaghani, Amirhossein Ahmadieh Yazdi, Peyman Zare, Mehdi Jaymand*, Rana Jahanban-Esfahlan*

Adv Pharm Bull. 2021;11(2): 233-247. doi: 10.34172/apb.2021.029

PMCID: PMC8046386 PMID: 33880345 Scopus ID: 85103156016

Article

PDF

Full Text

XML

Cited By:

Research Article

6. miR‐146a‐5p and miR-193a-5p Synergistically Inhibited the Proliferation of Human Colorectal Cancer Cells (HT-29 cell line) through ERK Signaling Pathway

Saeed Noorolyai , Elham Baghbani, Dariush Shanehbandi, Vahid Khaze Shahgoli, Amir Baghbanzadeh Kojabad, Behzad Mansoori, Khalil Hajiasgharzadeh, Ahad Mokhtarzadeh* , Behzad Baradaran*

Adv Pharm Bull. 2021;11(4): 755-764. doi: 10.34172/apb.2021.085

PMCID: PMC8642791 PMID: 34888223 Scopus ID: 85117194368

Article

PDF

Full Text

XML

Cited By:

Research Article

7. Investigation of the Effects of Apigenin, a Possible Therapeutic Agent, on Cytotoxic and SWH Pathway in Colorectal Cancer (HT29) Cells

Mustafa Cicek , Velid Unsal* , Arif Emre, Adem Doganer

Adv Pharm Bull. 2023;13(1): 188-195. doi: 10.34172/apb.2023.020

PMCID: PMC9871274 PMID: 36721804

Article

PDF

Full Text

XML

Cited By:

Research Article

8. Regulatory Effects of Apatinib in Combination with Piperine on MDM-2 Gene Expression, Glutathione Peroxidase Activity and Nitric Oxide level as Mechanisms of Cytotoxicity in Colorectal Cancer Cells

Mahshid Mohammadian* , Zakieh Rostamzadeh Khameneh, Soraya Emamgholizadeh Minaei, Meysam Ebrahimifar, Kosar Esgandari

Adv Pharm Bull. 2022;12(2): 404-409. doi: 10.34172/apb.2022.040

PMCID: PMC9106969 PMID: 35620326 Scopus ID: 85128208166

Article

PDF

Full Text

XML

Cited By:

Research Article

9. CD44 Suppression Improved the Chemosensitivity of HT-29 Colorectal Cancer Cells to 5-Fluorouracil and Inhibited Cell Migration

Souzan Najafi , Zohreh Rahimi, Behzad Mansoori, Ali Mohammadi, Fatemeh Mohammadnejad, Mohammad Amini, Ahad Mokhtazadeh, Zahra Asadzadeh, William Chi-Shing Cho* , Behzad Baradaran*

Adv Pharm Bull. 2023;13(3): 551-562. doi: 10.34172/apb.2023.053

PMCID: PMC10460815 PMID: 37646068

Article

PDF

Full Text

XML

Cited By:

Research Article

10. The Simultaneous Effects of miR-145-5p and hsa-let-7a-3p on Colorectal Tumorigenesis: In Vitro Evidence

Nazila Mozammel , Elham Baghbani, Mohammad Amini, Sheyda Jodeiry Zaer, Yalda Baghay Esfandyari, Maryam Tohidast, Seyed Samad Hosseini, Seyed Ali Rahmani, Ahad Mokhtarzadeh* , Behzad Baradaran*

Adv Pharm Bull. 2024;14(1): 231-240. doi: 10.34172/apb.2024.004

PMCID: PMC10997926 PMID: 38585468

Article

PDF

Full Text

XML

Cited By: